DSpace Home
→
Neurología
→
Enfermedades Desmielinizantes
→
Enfermedades Desmielinizantes.artículos
→
Browsing Enfermedades Desmielinizantes.artículos by Author

Browsing Enfermedades Desmielinizantes.artículos by Author "Farez, Mauricio Franco"

Now showing items 1-13 of 13

Cerebellar Ataxia With Extreme Photophobia Associated With Anti-SOX1 Antibodies

Alessandro, Lucas; Schachter, Daniel; Farez, Mauricio Franco; Varela, Francisco José (Sage, 2019-07)

Anti-SOX1 antibodies are associated with diverse neurological syndromes, targeting both the central (paraneoplastic cerebellar degeneration) and peripheral nervous systems (Lambert Eaton myasthenic syndrome, paraneoplastic ...
Disease activity impacts disability progression in primary progressive multiple sclerosis

Marrodán, Mariano; Bensi, Catalina; Pappolla, Agustín; Rojas, Juan Ignacio; Gaitán, María Inés; Ysrraelit, María Célica; Negrotto, Laura; Fiol, Marcela Paula; Patrucco, Liliana; Cristiano, Edgardo; Farez, Mauricio Franco; Correale, Jorge (Elsevier, 2019-12-14)

Background Although solid information on the natural history of primary progressive multiple sclerosis (PPMS) is available, evidence regarding impact of disease activity on PPMS progression remains controversial. Objective To ...
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Otero-Romero, Susana; Lebrun-Frenay, Christine; Reyes, Saúl; Amato, María Pía; Campins, Magda; Farez, Mauricio Franco; Filippi, Massimo; Hacohen, Yael; Hemmer, Bernhard; Juuti, Rosa; Magyari, Melinda; Oreja-Guevara, Celia; Siva, Aksel; Vukusic, Sandra; Tintoré, Mar (Sage, 2023-06-09)

Background: With the new highly active drugs available for people with multiple sclerosis (pwMS), vaccination becomes an essential part of the risk management strategy. Objective: To develop a European evidence-based ...
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Otero-Romero, Susana; Lebrun-Frenay, Christine; Reyes, Saúl; Amato, María Pía; Campins, Magda; Farez, Mauricio Franco; Filippi, Massimo; Hacohen, Yael; Hemmer, Bernhard; Juuti, Rosa; Magyari, Melinda; Oreja-Guevara, Celia; Siva, Aksel; Vukusic, Sandra; Tintoré, Mar (Wiley, 2023-06-09)

Background and purpose With the new highly active drugs available for people with multiple sclerosis (pwMS), vaccination becomes an essential part of the risk management strategy. We aimed to develop a European evidence-based ...
Food Allergies and Multiple Sclerosis

Farez, Mauricio Franco (BMJ Publishing Group, 2019-06-10)

The evidence on the association between allergies and multiple sclerosis (MS) disease activity is scarce. In this issue of JNNP, Fakih and colleagues report that patients with MS and food allergies have a higher disease ...
Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs

Silva, Berenice A.; Carnero Contentti, Edgar; Becker, Jefferson; Carranza, José I.; Correa-Díaz, Patricio E.; Galleguillos Goiry, Lorna; Garcea, Orlando; Gracia, Fernando; Hamuy, Fernando; Macías, Miguel Angel; Navas, Carlos; Nuñez, Sebastián; Rojas, Juan Ignacio; Farez, Mauricio Franco; Alonso, Ricardo; López, Pablo (Elsevier, 2023-06-20)

Introduction: The emergence of several therapeutic options in multiple sclerosis (MS), which significantly modify the immune system functioning, has led to the need for the consideration of additional factors, such as risk ...
Mucosal associated invariant T cell features and TCR repertoire characteristics during the course of Multiple Sclerosis

Carnero Contentti, Edgar; Farez, Mauricio Franco; Correale, Jorge (Frontiers Research Foundation, 2019-10-31)

Objective: To investigate the frequency, phenotype, function and longitudinal repertoire of Mucosal-associated invariant T (MAIT) cells in relapsing remitting (RRMS) and primary progressive MS (PPMS) patients Methods: ...
Obesity and the risk of Multiple Sclerosis. The role of Leptin

Marrodán, Mariano; Farez, Mauricio Franco; Balbuena Aguirre, María Eugenia; Correale, Jorge (Wiley Periodicals, 2021-02)

Objective: To investigate the effects of leptin on different T-cell populations, in order to gain more insight into the link between leptin and obesity. Methods: Three hundred and nine RRMS patients and 322 controls ...
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Farez, Mauricio Franco; Correale, Jorge; Armstrong, Melissa J.; Rae-Grant, Alexander; Gloss, David; Donley, Diane; Holler-Managan, Yolanda; Kachuck, Norman J.; Jeffery, Douglas; Beilman, Maureen; Michelson, David; Lee, Erin; Cox, Julie; Getchius, Tom; Sejvar, James; Narayanaswami, Pushpa; Gronseth, Gary (Lippincott Williams & Wilkins, 2019-08-28)

OBJECTIVE: To update the 2002 American Academy of Neurology (AAN) guideline regarding immunization and multiple sclerosis (MS). METHODS: The panel performed a systematic review and classified articles using the AAN ...
The role of infections in multiple sclerosis

Marrodán, Mariano; Alessandro, Lucas; Farez, Mauricio Franco; Correale, Jorge (Sage, 2019-01-14)

Several lines of evidence suggest that multiple sclerosis (MS), like other autoimmune diseases, may be triggered by microbial infections. Pathogens associated with development or exacerbation of MS include bacteria, such ...
The Immune Response in Multiple Sclerosis

Rodríguez Murúa, Sofía; Farez, Mauricio Franco; Quintana, Francisco J. (Annual Reviews, 2021-10-04)

Multiple sclerosis (MS) is a chronic autoimmune, inflammatory, and neurodegenerative disease that affects the central nervous system (CNS). MS is characterized by immune dysregulation, which results in the infiltration of ...
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

Tur, Carmen; Dubessy, Anne-Laure; Otero-Romero, Susana; Amato, María Pía; Derfuss, Tobías; Di Pauli, Franziska; Iacobaeus, Ellen; Mycko, Marcin; Abboud, Hesham; Achiron, Anat; Bellinvia, Angelo; Boyko, Alexey; Casanova, Jean-Laurent; Clifford, David; Dobson, Ruth; Farez, Mauricio Franco; Filippi, Massimo; Fitzgerald, Kathryn C.; Fonderico, Mattia; Gouider, Riadh (Stockton Press, 2022-02-23)

Over the recent years, the treatment of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) has evolved very rapidly and a large number of disease-modifying treatments (DMTs) are now available. ...
Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios

Carnero Contentti, Edgar; Rojas, Juan Ignacio; Criniti, Juan; López, Pablo Adrián; Daccach Marques, Vanessa; Soto de Castillo, Ibis; Tkachuk, Verónica A.; Marrodán, Mariano; Correale, Jorge; Farez, Mauricio Franco; Jin Kim, Ho; Hyun, Jae-Won; Messina, Silvia; Mariano, Romina; Rocca, Maria A.; Cacciaguerra, Laura; Filippi, Massimo; Palace, Jacqueline; Juryńczyk, Maciej (Elsevier B. V., 2022-05)

Background: The "1/3″ brain magnetic resonance imaging (MRI) criteria including 1) a lesion adjacent to the lateral ventricle and in the inferior temporal lobe, or 2) a juxtacortical lesion, or 3) a Dawson finger-type ...

Now showing items 1-13 of 13

Search DSpace

Advanced Search

Browse

All of DSpace
This Collection
- By Issue Date
- Authors
- Titles
- Subjects

Browsing Enfermedades Desmielinizantes.artículos by Author "Farez, Mauricio Franco"

Browsing Enfermedades Desmielinizantes.artículos by Author "Farez, Mauricio Franco"

Search DSpace

Browse

All of DSpace

This Collection

My Account